J. Murray & Associates

First Choice Neurology is thrilled to be an exhibitor at the 2026 American Academy of Neurology (AAN) Annual Meeting in Chicago, taking place April 18–22, 2026.

Suzana G. Mehle, EdD, MBA, DAAN, Director of Operations at South Miami Neurology, has been elected as one of the first Distinguished Colleagues of the American Academy of Neurology (DAAN).

First Choice Neurology invites the community to join Dr. Jeff Gelblum, one of the nation's leading neurology specialists, for an exclusive Facebook LIVE event on Friday, February 20, at 12:30 PM ET.

The American Epilepsy Society's (AES) Annual Meeting, taking place from December 5 to 9 in Atlanta, is the world's largest gathering for professionals dedicated to the science and clinical care of epilepsy.

First Choice Neurology (FCN) supports the Child Neurology Society (CNS) through exhibiting at the Annual Meeting, October 8–11, 2025, at the Charlotte Convention Center in Charlotte, North Carolina.

South Miami Neurology is proud to announce the addition of Dyanet Alvarez, MD, a board-certified neurologist with specialized training in epilepsy, to its team of esteemed physicians. Dr.

The FDA cleared Fujirebio's Lumipulse Plasma Ratio blood test for the early detection of amyloid plaques associated with Alzheimer's disease (AD). Lumipulse is the first in-vitro diagnostic (IVD) test used in the diagnosis of AD.

First Choice Neurology is proud to announce a groundbreaking partnership with NeuroDiscovery AI (NDAI), a national leader in artificial intelligence, data analytics, and clinical dashboarding for neurology.

Neurologists working in a hospital-integrated setting experience an average income reduction of $9,652

Naples Neurologist, Cory Lamar, MD, Joins First Choice Neurology